Sean Wieland
Stock Analyst at Piper Sandler
(1.80)
# 3,011
Out of 4,832 analysts
29
Total ratings
40%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Overweight | $25 → $40 | $24.53 | +63.07% | 2 | Feb 28, 2025 | |
| OMCL Omnicell | Upgrades: Overweight | $70 → $39 | $28.92 | +34.85% | 11 | Nov 3, 2023 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $7.14 | +1,581.85% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $62.51 | -90.40% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $60.15 | -26.85% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $143.99 | +60.43% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.38 | +3,843.09% | 5 | Feb 25, 2021 |
Privia Health Group
Feb 28, 2025
Maintains: Overweight
Price Target: $25 → $40
Current: $24.53
Upside: +63.07%
Omnicell
Nov 3, 2023
Upgrades: Overweight
Price Target: $70 → $39
Current: $28.92
Upside: +34.85%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $7.14
Upside: +1,581.85%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $62.51
Upside: -90.40%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $60.15
Upside: -26.85%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $143.99
Upside: +60.43%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.38
Upside: +3,843.09%